Anti-glucosaminidase IgG in Sera as a biomarker of host immunity against Staphylococcus aureus in orthopaedic surgery patients.
Anti-glucosaminidase IgG in Sera as a biomarker of host immunity against Staphylococcus aureus in orthopaedic surgery patients.
复制标题
DOI:
10.2106/jbjs.l.01654
复制
发表时间:
2013-01-01
期刊:
影响因子:
--
通讯作者:
Daiss, J. L.
中科院分区:
文献类型:
--
作者:
Gedbjerg, N.;LaRosa, R.;Daiss, J. L.
Background: Staphylococcus aureus infections remain a major complication of orthopaedic surgery. Although serum C-reactive protein is useful for diagnosis, there are no specific tests for host immunity that can assess a patient's risk for serious infection. On the basis of the identification of glucosaminidase as a potentially protective antigen in animal models, we tested the hypotheses that anti-glucosaminidase IgG (immunoglobulin G) levels vary in sera of mice and orthopaedic patients with Staphylococcus aureus infections and that physical and neutralizing titers correlate. Methods: In vitro ELISAs (enzyme-linked immunosorbent assays) were developed to quantify binding (physical) and enzyme-neutralizing (functional) anti-glucosaminidase IgG titers. The assays were validated with use of sera from naive, Staphylococcus aureus-challenged, and glucosaminidase-immunized mice. The physical, functional, and isotype titers of anti-glucosaminidase IgG were measured in sera from twenty-four patients with a confirmed Staphylococcus aureus infection following orthopaedic surgery and in sera from twenty noninfected patients. The specificity of the anti-glucosaminidase assay was evaluated by means of linear regression and receiver-operator characteristic curve analysis. Results: In mice, the analytic range of the physical titer assay for anti-glucosaminidase IgG was determined to be 1 ng/mL to 1 g/mL, and physical titers correlated with functional titers (p